Change cure to be able to raise patient of blame cellule lung cancer to live jointly period

A newest research shows as a result: A kind the name needs for love the target of appropriate is combined to medicaments with platinum kind the plan changing cure that is a foundation, what can raise patient of blame cellule lung cancer apparently is overall live period, apply to all histology inferior model blame cellule lung cancer. Researcher points out, this one new remedial program hopeful makes the new choice that is not cure of a gleam of of cellule lung cancer.

A newest research shows 　 　 as a result: A kind the name needs for love the target of appropriate is combined to medicaments with platinum kind the plan changing cure that is a foundation, what can raise patient of blame cellule lung cancer apparently is overall live period, apply to all histology inferior model blame cellule lung cancer. Researcher points out, this one new remedial program hopeful makes the new choice that is not cure of a gleam of of cellule lung cancer.

　 　 lung cancer is the matter of male cancer death that lives the first, live matter of the 2nd female cancer death. Statistical data shows, lung cancer is one of tumour with deadly top rate at present, the whole world has 1.35 million person every year to die at lung cancer about. There is 80% to be patient of blame cellule lung cancer in lung cancer patient, most patient already was terminal patient when diagnose. Changing cure at present is the standard choice that treats lung cancer, but its effect is finite, 5 years of survival rate of lung cancer patient have 16% only.

In 　 　 research, many 1100 clinical diagnose be IIIB period or the lung cancer patient of IV period is two groups by random cent, one group accepts what love needs appropriate combines a standard with platinum kind the cure of the plan changing cure that is a foundation, one group has the treatment of simplification cure plan. Study data shows, accepted the patient that love needs appropriate is treated, its live period have lengthen apparently, relatively contrast of the group live on average period 10.1 months extended 1.2 months.

　 　 loves to need appropriate is antibody of Chan Kelong of a kind of IgG1, it can grow with skin factor accepts put oneself in another's position (EGFR) particularity is united in wedlock, block is broken inside the EGFR signal that source sex distributes body interpose to guide conducts access, restrain the growth of tumor thereby. This medicaments has used at tumour of colonic, rectum and neck ministry permissibly in many countries treatment before this.